[FY2026 Medical Fee Revision] Accelerating Healthcare Consolidation, An Era Where the Government Intervenes in Management – Medical Tribune

News Highlights

The FY2026 medical fee revision will accelerate healthcare consolidation and usher in an era where the government directly intervenes in the management of medical institutions. The necessity of mid-to-long-term management and succession strategies, considering the revision cycle, will increase. Key discussion points will include maintaining facility standards through economies of scale, distributing the burden of capital investment, and utilizing tax schemes with an eye toward transitioning to specific medical corporations or social medical corporations.

M&A Medical Editorial Department’s Perspective

The implication that the FY2026 medical fee revision will bring about “an era where the government intervenes in management” is something that healthcare institution managers cannot overlook. It should be viewed not merely as a fee revision, but within the context of reorganizing the healthcare delivery system. In particular, it is expected that revision items linked to national policy objectives, such as achieving regional healthcare plans and promoting healthcare DX, will be strengthened. For example, incentives to promote the differentiation and collaboration of hospital bed functions, and expanded evaluation for remote and home healthcare utilizing ICT, can be anticipated. These suggest that for small to medium-sized medical institutions, which find it difficult to achieve economies of scale on their own, business succession through group formation or M&A could be a viable management strategy option for maintaining facility standards, distributing future capital investment burdens, and even enjoying tax benefits by transitioning to specific medical corporations or social medical corporations. This revision serves as an opportunity to redefine one’s own institution’s position and future vision, increasing the need to formulate proactive management strategies.

Discussion Points Indicated by This News

• The FY2026 revision will serve as a catalyst for promoting healthcare consolidation as national policy and deepening intervention in management.
• Revision items linked to national policy objectives, such as regional healthcare plans and the promotion of healthcare DX, are highly likely to be strengthened.
• For small to medium-sized medical institutions, pursuing economies of scale through group formation and M&A will be key to maintaining their management.
• Consideration of tax schemes with an eye toward transitioning to specific medical corporations or social medical corporations will become increasingly important.

Practical Questions Arising from This News

• What specific management indicators will be emphasized in this medical fee revision?
• What kind of information gathering and analysis is necessary to redefine our institution’s role in the region?
• When considering group formation or M&A, what schemes can be envisioned to maximize tax benefits?

If You Feel “Should I Consult Too?”

If the FY2026 medical fee revision is not just about changes in fees but also about reorganizing the healthcare delivery system and strengthening intervention in management, it is a good opportunity to re-examine your institution’s future vision. In particular, those who feel the need for role-sharing within the region, efficiency improvements through ICT utilization, and management strategies that leverage economies of scale should consult with an expert. Options such as business succession and group formation may lead to the sustainable development of your institution.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultations are available here.